The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Validation of a genomic classifier (ColoPrint) for predicting outcome in the T3-MSS subgroup of stage II colon cancer patients.
Ramon Salazar
Honoraria - Agendia
Josep Tabernero
Honoraria - Agendia
Victor Moreno
No relevant relationships to disclose
Ulrich Nitsche
No relevant relationships to disclose
Thomas Bachleitner-Hofmann
No relevant relationships to disclose
Giovanni Lanza
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Paul Roepman
Employment or Leadership Position - Agendia
Iris Simon
Employment or Leadership Position - Agendia
Stock Ownership - Agendia
Robert Rosenberg
No relevant relationships to disclose